Associations Between Low-Value Medication in Dementia and Healthcare Costs

BACKGROUND: Low-value medications (Lvm) provide little or no benefit to patients, may be harmful, and waste healthcare resources and costs. Although evidence from the literature indicates that Lvm is highly prevalent in dementia, evidence about the financial consequences of Lvm in dementia is limite...

Descripción completa

Detalles Bibliográficos
Autores principales: Platen, Moritz, Flessa, Steffen, Rädke, Anika, Wucherer, Diana, Thyrian, Jochen René, Scharf, Annelie, Mohr, Wiebke, Mühlichen, Franka, Hoffmann, Wolfgang, Michalowsky, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106620/
https://www.ncbi.nlm.nih.gov/pubmed/35482178
http://dx.doi.org/10.1007/s40261-022-01151-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106620/
https://www.ncbi.nlm.nih.gov/pubmed/35482178
http://dx.doi.org/10.1007/s40261-022-01151-9

Ejemplares similares